MALVERN, Pa. (AP) — MALVERN, Pa. (AP) — Neuronetics Inc. (STIM) on Tuesday reported a loss of $10.1 million in its second quarter.
The Malvern, Pennsylvania-based company said it had a loss of 15 cents per share.
The medical device company focused on psychiatric disorders posted revenue of $38.1 million in the period.
For the current quarter ending in September, Neuronetics said it expects revenue in the range of $37 million to $39 million.
The company expects full-year revenue in the range of $149 million to $155 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on STIM at https://www.zacks.com/ap/STIM
/AI%20(artificial%20intelligence)/Businessman%20touching%20the%20brain%20working%20of%20Artificial%20Intelligence%20(AI)%20Automation%20by%20Suttiphong%20Chandaeng%20via%20Shutterstock.jpg)
/Intel%20Corp_%20Santa%20Clara%20campus-by%20jejim%20via%20Shutterstock.jpg)
/EV%20in%20showroom%20by%20Robert%20Way%20via%20Shutterstock.jpg)
